Raymond Novak

4.5k total citations
140 papers, 3.8k citations indexed

About

Raymond Novak is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Raymond Novak has authored 140 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 50 papers in Pharmacology and 33 papers in Oncology. Recurrent topics in Raymond Novak's work include Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (19 papers) and Glutathione Transferases and Polymorphisms (16 papers). Raymond Novak is often cited by papers focused on Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (19 papers) and Glutathione Transferases and Polymorphisms (16 papers). Raymond Novak collaborates with scholars based in United States, South Korea and Hungary. Raymond Novak's co-authors include Kimberley J. Woodcroft, Sang Kyum Kim, Evan D. Kharasch, Richard C. Zangar, Sang G. Kim, Sang Geon Kim, Mikehl S. Hafner, Alice Hudder, B. Matkovics and Mohamed A. Abdelmegeed and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Raymond Novak

138 papers receiving 3.6k citations

Peers

Countries citing papers authored by Raymond Novak

Since Specialization

Citations

This map shows the geographic impact of Raymond Novak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Novak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Novak more than expected).

Fields of papers citing papers by Raymond Novak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Novak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Novak. The network helps show where Raymond Novak may publish in the future.

Co-authorship network of co-authors of Raymond Novak

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Novak. A scholar is included among the top collaborators of Raymond Novak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Novak. Raymond Novak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: Biomarkers of progression 2009 ·International Journal of Cancer ·(unknown), Fred R. Miller, Larry Tait, Jie Zheng, Raymond Novak	26
2	DNA damage is an early event in doxorubicin-induced cardiac myocyte death 2006 ·American Journal of Physiology-Heart and Circulatory Physiology ·Thomas J. L’Ecuyer, (unknown), Ronald Thomas, Raymond Novak, (unknown), (unknown), Richard Vander Heide	157
3	Role of mechanical and redox stress in activation of mitogen-activated protein kinases in primary cultured rat hepatocytes 2005 ·Biochemical Pharmacology ·Sang Kyum Kim, Kimberley J. Woodcroft, Soo Jin Oh, Mohamed A. Abdelmegeed, Raymond Novak	20
4	Acetoacetate Activation of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase in Primary Cultured Rat Hepatocytes: Role of Oxidative Stress 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Mohamed A. Abdelmegeed, Sang Kyum Kim, Kimberley J. Woodcroft, Raymond Novak	47
5	Insulin Signaling Regulates γ-Glutamylcysteine Ligase Catalytic Subunit Expression in Primary Cultured Rat Hepatocytes 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Sang Kyum Kim, Kimberley J. Woodcroft, (unknown), Raymond Novak	51
6	Insulin and Glucagon Regulation of Glutathione S-Transferase Expression in Primary Cultured Rat Hepatocytes 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Sang Kyum Kim, Kimberley J. Woodcroft, Raymond Novak	48
7	Progressive Resistance to Apoptosis in a Cell Lineage Model of Human Proliferative Breast Disease 2001 ·JNCI Journal of the National Cancer Institute ·(unknown), Cornelis J. Elferink, Raymond Novak	24
8	Identification of a Ubiquitination-Target/Substrate-Interaction Domain of Cytochrome P-450 (CYP) 2E1 2000 ·Drug Metabolism and Disposition ·Amit Kumar Banerjee, Thomas A. Kocarek, Raymond Novak	38
9	Cytotoxicity of trichloroethylene and S-(1,2-dichlorovinyl)-l-cysteine in primary cultures of rat renal proximal tubular and distal tubular cells 2000 ·Toxicology ·Brian S. Cummings, Richard C. Zangar, Raymond Novak, Lawrence H. Lash	29
10	The alcohol-inducible form of cytochrome P450 (CYP2E1): Role in toxicology and regulation of expression 2000 ·Archives of Pharmacal Research ·Raymond Novak, Kimberley J. Woodcroft	123
11	Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels. 1996 ·Drug Metabolism and Disposition ·(unknown), (unknown), (unknown), Raymond Novak	33
12	Pyridine induction of Sprague-Dawley rat renal cytochrome P4502E1: immunohistochemical localization and quantitation 1995 ·Toxicology Letters ·Jon A. Hotchkiss, Hyesook Kim, Fletcher F. Hahn, Raymond Novak, Alan R. Dahl	7
13	3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue. 1995 ·Drug Metabolism and Disposition ·(unknown), Subrayal M. Reddy, Raymond Novak	18
14	Regulation of cytochrome P-4501A and cytochrome P-4502E induction in the rat during the production of interferon alpha/beta. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Alastair E. Cribb, (unknown), (unknown), Raymond Novak, K W Renton	30
15	Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats 1994 ·Biochemical Pharmacology ·(unknown), Sang Geon Kim, (unknown), Raymond Novak, Nak Doo Kim	58
16	Enhanced Glutathione S-Transferase 7-7 Expression in Rat Hepatic Cytosol Following Treatment with Pyrrole 1993 ·Biochemical and Biophysical Research Communications ·Thomas Primiano, J. Gandy, J. Lyndal York, Raymond Novak	4
17	Changes in adult metabolism of aflatoxin B₁ in rats neonatally exposed to diethylstilbestrol. Alterations in α-class glutathione S-transferases 1992 ·Carcinogenesis ·Richard C. Zangar, David L. Springer, (unknown), Raymond Novak, Thomas Primiano, Donald R. Buhler	10
18	Comparison of peroxide metabolism enzymes in organs of congenic mice 1978 ·Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·Raymond Novak, B. Matkovics, Sz.I. Varga, L. Szabó	6
19	A comparative study of some more important experimental animal peroxide metabolism enzymes 1977 ·Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·B. Matkovics, Raymond Novak, (unknown), László Szabó, Sz.I. Varga	82
20	Nuclear Magnetic Resonance Studies of Barbiturate-Phospholipid Interactions 1976 ·Molecular Pharmacology ·Raymond Novak, T. J. Swift	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact